GlassScriptPhysician profile
Suman K Sinha
NPI 1114947900
$13,316.26
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,153 · 2020: $277 · 2021: $559 · 2022: $1,283 · 2023: $1,542 · 2024: $7,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,518 · Food and Beverage: $2,357 · Travel and Lodging: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,517.76 |
| Food and Beverage | $2,356.75 |
| Travel and Lodging | $1,169.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,839.34 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $1,537.27 | 2019-2024 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,334.89 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $735.76 | 2019-2024 | Ofev |
| Mylan Specialty L.P. | $489.45 | 2019-2024 | Yupelri |
| Ethicon INC. | $470.12 | 2019 | |
| Genentech USA, INC. | $397.47 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $192.64 | 2019-2023 | Dupixent |
| Insmed, INC. | $191.08 | 2019-2024 | Arikayce |
| Genzyme Corporation | $186.31 | 2022-2024 | |
| Sunovion Pharmaceuticals INC. | $126.33 | 2019 | |
| Tactile Systems Technology INC | $97.62 | 2022 | |
| Baxter Healthcare | $85.85 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $71.26 | 2019-2020 | |
| Gilead Sciences, INC. | $58.23 | 2021-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $52.40 | 2021-2024 | Recarbrio, Zerbaxa |
| Grifols USA, LLC | $51.03 | 2019-2024 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $46.70 | 2023 | Acthar |
| Mallinckrodt Enterprises LLC | $45.04 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.31 | 2023 | Glassia |
| Advanced Respiratory, INC | $37.17 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $31.11 | 2024 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $28.27 | 2023 | Xarelto |
| Inogen, INC. | $27.86 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Covidien LP | $27.06 | 2019 | |
| United Therapeutics Corporation | $19.84 | 2023 | Tyvaso |
| Shionogi INC | $19.66 | 2024 | Fetroja |
| Biofire Diagnostics, LLC | $18.05 | 2019 | |
| Veran Medical Technologies, INC. | $15.15 | 2019 | |
| Amgen INC. | $14.76 | 2024 | Tezspire |
| Electromed, INC. | $13.74 | 2023 | Smartvest |
| Circassia INC. | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suman Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.